Benvenuto nella sezione riservata ai Comunicati Stampa.

In queste pagine, ti offre la possibilità di diffondere gratuitamente e senza alcuna limitazione i tuoi comunicati.

Crea un Nuovo Account

Per poter inserire comunicati stampa su, è necessario creare prima un proprio account.

Inserisci un Comunicato Stampa

Se sei già un utente registrato, vai alla pagina di login per inserire un nuovo comunicato.

Gestisci i Comunicati Stampa inviati

Gli utenti registrati hanno la possibilità di verificare la pubblicazione dei propri comunicati tramite un pannello di controllo riservato.

Richiedi una Nuova Password

Per gli utenti che hanno dimenticato la propria password oppure desiderano modificare quella esistente.

I Comunicati sul tuo Sito

Hai ora la possibilità di visualizzare i comunicati stampa di sul tuo sito mediante un widget, di cui puoi personalizzare sia il contenuto che il formato.

Feed RSS per la notifica dei nuovi comunicati pubblicati su Gli ultimi comunicati stampa

Regulated information - Ageas agrees to sell its Life insurance business in Hong Kong to JD Capital

Ageas has agreed to sell its Life insurance business in Hong Kong((1)) to JD Capital (Beijing Tongchuangjiuding Investment Management Co.) for a cash consideration of HKD 10,688 million (EUR 1,230 million((2))). The transaction is expected to be completed within the first half of 2016 and is subject to regulatory approvals, customary closing conditions and JD Capital's shareholder approval((3))...
Thomson Reuters 30/08/2015 11:00

Philips Introduces IntelliSpace Cardiovascular at ESC Congress 2015

Royal Philips (NYSE: PHG, AEX: PHIA) today announced the European debut of IntelliSpace Cardiovascular, a web-enabled image and information management system  that provides sophisticated tools to access, analyze and share cardiovascular images and information anytime, from virtually anywhere. Showcased at the Philips Booth (#G200) during ESC Congress 2015,  IntelliSpace Cardiovascular marks the next generation of image and cardiology informatics solutions, serving as a nexus of interoperability that allows all care team members to access data and launch sophisticated clinical applications, like IntelliSpace Portal, or IntelliSpace ECG within a single workspace.
PR Newswire 30/08/2015 10:00

UAE Portal Launched Containing the Largest Property Database, a real estate portal launched in January 2014 is set to become the primary resource for everybody interested in the Dubai property market.  With a database of over 30,000 property listings throughout Dubai and the UAE, the portal provides extensive details for buying and renting opportunities across both residential and commercial sectors.  With an ever expanding portfolio of properties, an intuitive website design and ranking in over 55 countries, the portal has quickly attracted many of Dubai's prominent estate agents including Aston Pearl, Binayah Real Estate, Dacha, Elysian, Haus & Haus, Emirates Homes and Lannhill Real Estate within the few month of its launch.
PR Newswire 30/08/2015 06:00

Philips Introduces HeartModel A.I. at ESC Congress 2015

Royal Philips (NYSE: PHG, AEX: PHIA) today announced the European debut of HeartModelA.I., a new Anatomically Intelligent Ultrasound (AIUS) tool that brings advanced quantification, automated 3D views and robust reproducibility to echocardiology. Philips' fastest 3D AIUS ultrasound measurement method was unveiled today on its EPIQ 7 ultrasound system, Philips' first ultrasound with Anatomic Intelligence capabilities, during ESC Congress 2015 in London.
PR Newswire 29/08/2015 10:00

Global & USA BioSimilar Market Analysis Report 2015-2021

The highly awaited US Biosimilar market will be initiated in September as Sandoz launches its highly awaited filigrastim biologic, Zarxio. How will the global market react? Will biosimilars explode into the biologics market? The author reveals that biosimilars could save the US economy up to $250 billion within the next seven years. A newly published Global and USA Biosimilar Market Analysis to 2021 indicates that there is tremendous interest by big pharma and generics companies in this industry who are focusing on biosimilar development of Avastin, Enbrel, Herceptin, Humira and Rituxan. Global Biosimilar Market While the U.S. has approved only one biosimilar therapeutic; Japan, Australia and Europe have approved six, eight and 19 biosimilars respectively. Already, biosimilars have an exemplary safety track record in the E.U., Japan, and Canada where biosimilars are regularly competing against biologics for nearly seven years. The E.U. was the first geographic market to develop the...
PR Newswire 28/08/2015 20:10

12th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production

The 2015 12th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production is the most recent study of biotherapeutic developers and contract manufacturing organizations' current and projected future capacity and production. The report contains the industry's definitive, quantitative analysis and includes 12 years of biopharma trends as well as a review of current opportunities and in-depth coverage by several subject matter experts of critical issues affecting the industry. The survey includes responses from 237 responsible individuals at biopharmaceutical manufacturers and contract manufacturing organizations from 28 countries. The methodology also includes responses from an additional 164 direct suppliers of raw materials, services and equipment to this industry. Top trends identified include: - Focus today is on manufacturing and productivity - Operations budgets are growing, from R&D to new capital equipment - Single-use systems and disposable devices among...
PR Newswire 28/08/2015 20:10

Market Analysis and Prospects of Household Water Filter Industry in China 2015-2020

The quality of drinking water has attracted increasing attention of the public in China in recent years. However, it is noteworthy that compared with the wide coverage of household water filter products in the U.S. and Europe which is 90% and that of developed Asian countries which is 70%, the product coverage in China is merely 2%. According to The First Water Treatment Product Consumer Research in China, only 25% of interviewees were satisfied with the tap water quality, while 49.6% had concerns on the quality of water in terms of impurities, bacteria, minerals and pH value. In the meantime, 62.4% of interviewees wished to guarantee the drinking water quality for the elderly and children, as well as to improve living quality. Hence, household water filter industry in China demonstrates huge market potentials and numerous opportunities. In this report, the author further discloses market potential and commercial opportunities for household water filter industry in China....
PR Newswire 28/08/2015 20:10

Vai all'elenco completo...